Follow the people · Insider

BM

Berndt Modig

Insider · Chief Executive Officer · PHVS

Berndt Modig files insider transactions with the SEC as a chief executive officer of Pharvaris (PHVS). We hold 6 disclosed purchases and sales filed since 3 May 2016, 3 of them in the last 90 days.

  • Files forPHVS
  • Disclosed buys and sells6 in all, 3 in the last 90 days
  • Last disclosure18 August 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 9 April 202614 August 2026Chief Executive Officer · Pharvaris (PHVS)8 Form 4 lines · source: SEC Form 4
  • Filed 15 April 202115 April 2021Director · Sio Gene Therapies (SIOX)1 Form 4 line · source: SEC Form 4
  • Filed 15 April 201915 April 2020Director · Axovant Sciences (AXGT)2 Form 4 lines · source: SEC Form 4
  • Filed 29 April 201615 March 2018Director · Axovant Sciences (AXON)5 Form 4 lines · source: SEC Form 4

Everything they disclosed

16 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.